Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039497, "name": "Senores Pharma.", "stock_name": "Senores Pharma.", "full_name": "Senores Pharmaceuticals Ltd", "name_url": "stocks-analysis/senores-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,285.30", "chg": -7.45, "chgp": "-0.58%", "dir": -1, "prev_price": "1,292.75", "mcapval": "5,919.27 Cr", "mcap": "Small Cap", "scripcode": "544319", "symbol": "SENORES", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE0RB801010", "curr_date": "Jun 23, 02:38 PM", "curr_time": "14:40 PM", "last_traded_at": "Jun 23, 02:38 PM IST", "bse_nse_vol": "2.24 lacs", "exc_status": "Active", "traded_date": "Jun 23, 2026", "traded_date_str": "2026 06 23", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Senores Pharmaceuticals Gains 1.85%: 6 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-185-6-key-factors-driving-the-weeks-momentum-4064946", "imagepath": "", "date": "2026-06-20 10:00:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Jun:</strong> New 52-week and all-time high at Rs.1,306.20; upgraded to Buy rating</p>\n <p><strong>16 Jun:</strong> Stock declined 2.01% amid broader market gains</p>\n <p><strong>17 Jun:</strong> Price recovery with 1.13% gain supported by steady volumes</p>\n <p><strong>18 Jun:</strong> New 52-week and all-time high at Rs.1,318.25; outperformed Sensex</p>\n <p><strong>19 Jun:</strong> Marginal gain of 0.09% closing at Rs.1,315.15; slight Sensex dip</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cla..." }, { "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1318.25", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs-131825-4061197", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_priceRelatedfactors_4061197.png", "date": "2026-06-18 10:41:10", "description": "With a remarkable surge to Rs 1318.25 on 18 Jun 2026, Senores Pharmaceuticals Ltd has reached a new 52-week and all-time high, propelled by a confluence of strong technical signals and sustained price momentum." }, { "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,312 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-at-rs1312-on-18-jun-2026-4060923", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_priceRelatedfactors_4060923.png", "date": "2026-06-18 10:03:57", "description": "Extending its recent rally, Senores Pharmaceuticals Ltd touched a fresh all-time high of Rs 1,312 on 18 Jun 2026, outperforming its sector and the broader market with a notable 3.07% gain on the day." }, { "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,306.2 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-at-rs-130620-4054463", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_priceRelatedfactors_4054463.png", "date": "2026-06-15 12:28:04", "description": "" }, { "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1306.2", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs13062-4054230", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_priceRelatedfactors_4054230.png", "date": "2026-06-15 10:01:35", "description": "With a remarkable ascent from Rs 507 to Rs 1306.2 over the past year, Senores Pharmaceuticals Ltd has more than doubled its share price, reaching a fresh 52-week high on 15 Jun 2026. This milestone underscores a sustained momentum driven by a confluence of robust technical indicators and steady fundamental growth." }, { "title": "Senores Pharmaceuticals Upgraded to Buy on Strong Technicals and Financial Momentum", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-upgraded-to-buy-on-strong-technicals-and-financial-momentum-4053686", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_mojoScore_4053686.png", "date": "2026-06-15 08:15:58", "description": "Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade comes amid robust stock price appreciation, strong quarterly results, and positive institutional interest, positioning the company favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Senores Pharmaceuticals Ltd Sees Strong Technical Momentum Shift Amid Robust Price Gains", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-sees-strong-technical-momentum-shift-amid-robust-price-gains-4053628", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_technicaldot_4053628.png", "date": "2026-06-15 08:05:56", "description": "Senores Pharmaceuticals Ltd has witnessed a significant price momentum shift, marked by a strong technical uptrend and an upgrade in its MarketsMOJO Mojo Grade from Hold to Buy. The stock’s recent surge of 11.35% in a single day, coupled with robust weekly and monthly technical indicators, signals renewed investor confidence in this small-cap pharmaceutical player." }, { "title": "Senores Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-buy-4052769", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SenoresPharmace_mojoScore_4052769.png", "date": "2026-06-14 10:10:29", "description": "Senores Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 12 June 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 14 June 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance." }, { "title": "Senores Pharmaceuticals Drops 7.44%: Volatility and Technical Shifts Define Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-drops-744-volatility-and-technical-shifts-define-week-4051752", "imagepath": "", "date": "2026-06-13 15:05:32", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Stock opens with a significant gap down, closing at Rs.1,067.75 (-4.49%)</p>\n <p><strong>2 June:</strong> Technical momentum shifts amid mixed indicator signals, stock closes at Rs.1,036.55 (-2.92%)</p>\n <p><strong>3 June:</strong> Minor recovery with a 1.18% gain, closing at Rs.1,048.80</p>\n <p><strong>4 June:</strong> Slight decline of 0.56%, closing at Rs.1,042.95</p>\n <p><strong>5 June:</strong> Week ends with a 0.78% drop, closing at Rs.1,034.80</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week O..." } ], "total": 258, "sid": "10039497", "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497" }, "announcements": [ { "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015", "datetime": "10-Jun-2026", "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding update in terms of Regulation 30(5) of SEBI (LODR) Regulations 2015", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer", "datetime": "10-Jun-2026", "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Cessation of Company Secretary and Compliance Offer w.e.f. June 10 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "09-Jun-2026", "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on June 12 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Jun: New 52-week and all-time high at Rs.1,306.20; upgraded to Buy rating

16 Jun: Stock declined 2.01% amid broader market gains

17 Jun: Price recovery with 1.13% gain supported by steady volumes

18 Jun: New 52-week and all-time high at Rs.1,318.25; outperformed Sensex

19 Jun: Marginal gain of 0.09% closing at Rs.1,315.15; slight Sensex dip

Week Open

Read full news article

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1318.25

2026-06-18 10:41:10

With a remarkable surge to Rs 1318.25 on 18 Jun 2026, Senores Pharmaceuticals Ltd has reached a new 52-week and all-time high, propelled by a confluence of strong technical signals and sustained price momentum.

Read full news article

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,312 as Momentum Builds Across Timeframes

2026-06-18 10:03:57

Extending its recent rally, Senores Pharmaceuticals Ltd touched a fresh all-time high of Rs 1,312 on 18 Jun 2026, outperforming its sector and the broader market with a notable 3.07% gain on the day.

Read full news article

Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,306.2 as Momentum Builds Across Timeframes

2026-06-15 12:28:04

Read full news article

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1306.2

2026-06-15 10:01:35

With a remarkable ascent from Rs 507 to Rs 1306.2 over the past year, Senores Pharmaceuticals Ltd has more than doubled its share price, reaching a fresh 52-week high on 15 Jun 2026. This milestone underscores a sustained momentum driven by a confluence of robust technical indicators and steady fundamental growth.

Read full news article

Senores Pharmaceuticals Upgraded to Buy on Strong Technicals and Financial Momentum

2026-06-15 08:15:58

Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade comes amid robust stock price appreciation, strong quarterly results, and positive institutional interest, positioning the company favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Senores Pharmaceuticals Ltd Sees Strong Technical Momentum Shift Amid Robust Price Gains

2026-06-15 08:05:56

Senores Pharmaceuticals Ltd has witnessed a significant price momentum shift, marked by a strong technical uptrend and an upgrade in its MarketsMOJO Mojo Grade from Hold to Buy. The stock’s recent surge of 11.35% in a single day, coupled with robust weekly and monthly technical indicators, signals renewed investor confidence in this small-cap pharmaceutical player.

Read full news article

Senores Pharmaceuticals Ltd is Rated Buy

2026-06-14 10:10:29

Senores Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 12 June 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 14 June 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.